{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for "ORPHAN DRUG" in comments (approximate match)
Status:
Investigational
Source:
NCT02829099: Phase 1 Interventional Completed Advanced Solid Neoplasms
(2016)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04346888: Phase 2 Interventional Completed Myasthenia Gravis
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04380519: Phase 2/Phase 3 Interventional Completed COVID-19
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:zilovertamab vedotin [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02655510: Phase 1/Phase 2 Interventional Completed Alcoholic Hepatitis
(2016)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04022213: Phase 2 Interventional Recruiting Desmoplastic Small Round Cell Tumor
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03516591: Phase 1 Interventional Completed Myelodysplastic Syndrome (MDS)
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03424603: Phase 1 Interventional Completed B-cell Lymphoma
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04019288: Phase 1/Phase 2 Interventional Completed Platinum-Resistant Fallopian Tube Carcinoma
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04478695: Phase 1 Interventional Terminated Relapsed or Refractory Acute Myeloid Leukemia
(2020)
Source URL:
Class:
PROTEIN
